MedPath

Analgesic Effect of Ultrasound Guided Maxillary Nerve Block in Trigeminal Neuralgia

Not Applicable
Withdrawn
Conditions
Trigeminal Neuralgia
Interventions
Procedure: US guided block of maxillary nerve
Registration Number
NCT06129071
Lead Sponsor
Varazdin General Hospital
Brief Summary

This is a study about the dynamics and effects of ultrasound guided maxillary nerve block in trigeminal neuralgia

Detailed Description

Standard pharmacological treatment for trigeminal neuralgia is often insufficient. In this setting, patients often suffer trough everyday activities and quality of life is disturbed substantially.

In this prospective clinical study, analgesic effect of ultrasound (US) guided maxillary nerve block will be investigated, in order to prolong pain-free time, reduce the use of standard analgesics, as well as atypical ones (e.g. antiepileptic drugs and antidepressants).

Characteristics of US guided maxillary nerve block will pain investigated: reduction of pain (decrease of VAS score), duration of pain-free period, pain level during the procedure.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • patients with trigeminal neuralgia
Exclusion Criteria
  • allergy to local anesthetics
  • local infection at the site of needle puncture
  • parotitis
  • serious liver disease
  • use of antiarrhythmics group III (eg amiodarone)
  • anticoagulant or antithrombotic drugs
  • lactation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
US block of maxillar nerveUS guided block of maxillary nerveExtraoral ultrasound-guided block of the maxillary nerve will be performed using an ultrasound device. After visualisation of the pterygomandibular space, of the maxillary artery and the mandibular nerve next to it, at a depth of 2-4 cm, the detection of the maxillary artery is confirmed by Color Doppler. A needle enters between the coronoid and condylar processes, using the "out of plane" technique, near the maxillary artery, and after negative aspiration, local anesthetic levobupivacaine (0,5%, 2 mL) combined with triamcinolonacetonid (2mL).
Primary Outcome Measures
NameTimeMethod
Time without pain26 weeks

Patients will report to the investigator when pain starts to rise - and the amount of time form the procedure to the reporting will be recorded

Secondary Outcome Measures
NameTimeMethod
Trend of pain levelPain level at three time points: 1 month, 3 months and 6 months after the procedure

Pain will be graded according to visual analogue scale, 0 meaning no pain, 10 meaning the worse pain possible

Time to sart of the action of the blockImmediately after the procedure

Time from the procedure till the pain is reduced, in minutes

Pain level when anesthesia is appliedImmediately after the procedure

Pain will be graded according to visual analogue scale, 0 meaning no pain, 10 meaning the worse pain possible

Trial Locations

Locations (1)

Varazdin General Hospital

🇭🇷

Varaždin, Croatia

© Copyright 2025. All Rights Reserved by MedPath